Literature DB >> 18475157

Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension.

Joseph Fomusi Ndisang1, Nina Lane, Ashok Jadhav.   

Abstract

BACKGROUND: Aldosterone is a mineral corticoid hormone that is produced in response to angiotensin-II, and like angiotensin-II, stimulates inflammation, oxidative stress, and fibrosis by activating nuclear factor-kappaB and activating protein-1. Recent evidence, however, indicates that aldosterone stimulates phospholipase C and activates nuclear factor-kappaB and activating protein-1. Although the heme oxygenase system is cytoprotective, its effects on aldosterone-phospholipase C signaling in deoxycorticosterone acetate (DOCA-salt) hypertension, a model of aldosteronism, and spontaneously hypertensive rat, a genetic model of human essential hypertension, have not been fully characterized.
METHODS: In the present study, the heme oxygenase inducer, hemin, was given to spontaneously hypertensive and deoxycorticosterone acetate hypertensive rats, and the effects on blood pressure, aldosterone, nuclear factor-kappaB, activating protein-1, phospholipase C, and inositol 1,4,5-triphosphate were examined.
RESULTS: Hemin therapy restored physiological blood pressure to spontaneously hypertensive rats (209.9 +/- 0.9 to 127.3 +/- 0.85 mmHg, n = 10, P < 0.01) and to deoxycorticosterone acetate salt hypertensive rats (195.7 +/- 1.8 vs.132.5 +/- 2.1 mmHg; P < 0.01, n = 10), but had no effect on age-matched normotensive Wistar-Kyoto or Sprague-Dawley strains. The antihypertensive effect was accompanied by enhanced heme oxygenase activity, upregulated cyclic guanosine monophosphate-protein kinase G signaling, increased superoxide dismutase activity, and the potentiation of total antioxidant capacity, whereas aldosterone, activating protein-1, and nuclear factor-kappaB were reduced. Furthermore, hemin suppressed phospholipase C activity, attenuated inositol 1,4,5-triphosphate, and reduced resting intracellular calcium in the aorta.
CONCLUSION: Collectively, our results suggest that the concomitant depletion of aldosterone, phospholipase C-inositol 1,4,5-triphosphate activity, resting intracellular calcium and the corresponding decline of inflammatory, and oxidative insults may account for the antihypertensive effects of hemin in deoxycorticosterone acetate hypertension and spontaneously hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18475157     DOI: 10.1097/HJH.0b013e3282fad93d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Haemin enhances the in vivo efficacy of artemether against juvenile and adult Schistosoma mansoni in mice.

Authors:  Naglaa Mohamed El-Lakkany; Sayed Hassan Seif El-Din
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

Review 2.  Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.

Authors:  Joseph Fomusi Ndisang
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

3.  Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure.

Authors:  Utpal Sen; Poulami Basu; Oluwasegun A Abe; Srikanth Givvimani; Neetu Tyagi; Naira Metreveli; Karan S Shah; John C Passmore; Suresh C Tyagi
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-27

4.  Mechanisms by which heme oxygenase rescue renal dysfunction in obesity.

Authors:  Joseph Fomusi Ndisang; Shuchita Tiwari
Journal:  Redox Biol       Date:  2014-09-06       Impact factor: 11.799

5.  The heme oxygenase system suppresses perirenal visceral adiposity, abates renal inflammation and ameliorates diabetic nephropathy in Zucker diabetic fatty rats.

Authors:  Joseph Fomusi Ndisang; Ashok Jadhav; Manish Mishra
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

6.  The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes.

Authors:  Tatiana Ntube Salley; Manish Mishra; Shuchita Tiwari; Ashok Jadhav; Joseph Fomusi Ndisang
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.